Physician profile
Adora Chatman
NPI 1659092690
$1,338.06
in general payments reported to CMS, 2019-2025
9 companies · $1,183 in 2025
The $1,183 reported for 2025 was more than what 89% of Family providers received nationally (typical 2025 total: $167).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2024: $155 · 2025: $1,183.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,338.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,338.06 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Glaxosmithkline, LLC. | $286.08 | 2025 | Nucala |
| Lilly USA, LLC | $275.37 | 2024-2025 | Omvoh |
| Eisai INC. | $270.49 | 2025 | |
| Takeda Pharmaceuticals U.S.A., INC. | $153.24 | 2025 | Hyqvia |
| Grifols USA, LLC | $127.89 | 2025 | Xembify |
| Novo Nordisk INC | $122.83 | 2025 | Ozempic |
| Lundbeck LLC | $47.10 | 2025 | Vyepti |
| Amneal Pharmaceuticals LLC | $28.48 | 2025 | Crexont |
| Janssen Biotech, INC. | $26.58 | 2025 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Adora Chatman listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.